Insider Transactions in Q2 2025 at Collegium Pharmaceutical, Inc (COLL)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2025
|
John Gordon Freund Director |
SELL
Open market or private sale
|
Direct |
6,601
-8.54%
|
$198,030
$30.62 P/Share
|
|
Jun 09
2025
|
John Gordon Freund Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+16.26%
|
$195,000
$13.45 P/Share
|
|
May 15
2025
|
John Gordon Freund Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,791
+13.59%
|
-
|
|
May 15
2025
|
Rita J. Balice Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,791
+14.82%
|
-
|
|
May 15
2025
|
Garen G Bohlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,791
+13.59%
|
-
|
|
May 15
2025
|
Nancy Lurker Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,791
+30.31%
|
-
|
|
May 15
2025
|
John A. Fallon Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,791
+13.16%
|
-
|
|
May 15
2025
|
Carlos V Paya Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,582
+50.0%
|
-
|
|
May 15
2025
|
Gino Santini Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,791
+10.28%
|
-
|